PMA device
The Spanner Temporary Prostatic Stent
Srs Medical · Stent, Urethral, Prostatic, Semi-Permanent (NZC, Class III) · First FDA decision Dec 14, 2006, newest Oct 7, 2022Enlarged prostate (BPH)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
4
Naming "Spanner Temporary"
MAUDE reports
8
Brand "Spanner Temporary", since 2015
PubMed studies
3
Mentioning "Spanner Temporary"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing The Spanner Temporary Prostatic Stent
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- The Spanner Temporary Prostatic StentPMA supplement
P060010-S013 · Decided Oct 7, 2022 · 837 days after receipt · Panel Track
Device type: Stent, urethral, prostatic, semi-permanent (NZC) · GI, Urology & Nephrology
- THE SPANNER TEMPORARY PROSTATIC STENTPMA supplement
P060010-S011 · Decided Aug 28, 2013 · 126 days after receipt · Normal 180 Day Track No User Fee
Device type: Stent, urethral, prostatic, semi-permanent (NZC) · GI, Urology & Nephrology
- THE SPANNER TEMPORARY PROSTATIC STENTPMA supplement
P060010-S001 · Decided Feb 12, 2008 · 145 days after receipt · Normal 180 Day Track
Device type: Stent, urethral, prostatic, semi-permanent (NZC) · GI, Urology & Nephrology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Spanner Temporary", any status and sponsor, newest update first.
British University In EgyptAcademic, hospital or other
NCT07492576 · 22 participants (planned) · Start Mar 19, 2026 · Primary completion Dec 29, 2026
Device: GBR surgery using magnesium Shield · For: Immediate Implant Placement
Sites: Cairo, Egypt
SRS MedicalNot on our public-company list
NCT02643849 · 107 participants · Start Aug 2016 · Primary completion Jan 2019
Device: The Spanner Temporary Prostatic Stent · For: Urinary Retention
Sites: Daytona Beach, Florida; Oxford, Florida; Palm Harbor, Florida · 6 sites in all
Federal University of Juiz de ForaAcademic, hospital or other
NCT03973190 · 30 participants (planned) · Start Aug 1, 2018 · Primary completion Jun 25, 2020
Device: ISQ analysis · For: Alveolar Osseous Loss
Sites: Juiz de Fora, Brazil
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Spanner Temporary", and for the whole product code for context.
This brand
8 reports: 0 malfunction, 8 injury, 0 death
Whole product code NZC
8 reports: 0 malfunction, 8 injury, 0 death
Newest reports for this brand
1000305746-2023-00001 · Received Mar 23, 2023 · Event dated Sep 13, 2014
Device type: Stent, Urethral, Prostatic, Semi-Permanent (NZC)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Urinary Retention
1000305746-2023-00002 · Received Mar 23, 2023 · Event dated Oct 15, 2014
Device type: Stent, Urethral, Prostatic, Semi-Permanent (NZC)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Urinary Retention
1000305746-2023-00003 · Received Mar 23, 2023 · Event dated Dec 23, 2014
Device type: Stent, Urethral, Prostatic, Semi-Permanent (NZC)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Urinary Retention
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Spanner Temporary"[tiab]. The summary above synthesizes these.
- Extended Use of The Spanner® Temporary Prostatic Stent in Catheter-Dependent Men with Comorbidities.
Cambio AJ, Roach RM, Arnold P, et al. · Adv Urol · 2022
- Experience with the spanner prostatic stent in patients unfit for surgery: an observational study.
Grimsley SJ, Khan MH, Lennox E, et al. · J Endourol · 2007
- First experiences with the Spannerࡊ temporary prostatic stent for prostatic urethral obstruction.
Goh MH, Kastner C, Khan S, et al. · Urol Int · 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.